期刊文献+

乙型肝炎病毒基因变异及其临床意义

Hepatitis B virus gene mutation and clinical significance
下载PDF
导出
摘要 乙型肝炎病毒(hepatitis Bvirus,HBV)属于嗜肝DNA病毒科,由于HBV复制过程中HBVDNA聚合酶缺乏校正功能,导致HBV容易发生突变。HBV基因组中四个开放读码区均可发生变异,其中某些关键位点的变异可能与疫苗接种失败、肝炎的慢性化、重型肝炎、肝癌的发生有一定关系,并可能影响肝炎的治疗。本文综述了HBV基因关键位点变异及其临床意义。 The hepatitis B virus (HBV), a hepadnavirus, is partially double stranded DNA virus. HBV mutation may occur because of correctional function absence in HBV DNA polymer'ase during viral replicate cycle. HBV DNA has a very compact coding organization with four partially overlapping open reading frames (ORFs) and HBV mutations have been found in these ORFs. Mutations at crucial points may be related to the failure of vaccine inoculation, hepatitis chronicity, hepatitis aggravation, hepatocellular carcinoma; and may influence the treatment of hepatitis. This article reviewed HBV mutations at crucial points and their clinical signiflcances.
出处 《世界感染杂志》 2007年第1期6-9,共4页 World Journal of Infection
关键词 乙型肝炎病毒 基因变异 临床意义 Hepatitis B virus (HBV) gene mutation clinical significances
  • 相关文献

参考文献34

  • 1Maddrey WC. Hepatitis B. an important public health issue [J]. J Med Virol, 2000, 61(3): 362-366.
  • 2Mathet VL, Feld M, Espinola L, et al. Hepatitis B Virus S Gene Mutations in a Patient With Chronic Active Hepatitis With Circulating Anti-HBs Antibodies [J]. J Med Virol, 2003, 69(1):18-26.
  • 3Steward MW, Partidos CD, D'Mello F, et al. Specificity of antibodies reactive with hepatitis B surface antigen following immunisation with synthetic peptides [J]. Vaccine, 1993, 11(14): 1405-1414.
  • 4Marigold CM, Streeck RE. Mutational analysis of the cysteine residues in the hepatitis B virus small envelope protein [J]. J Virol,1993, 67(8): 4588-4597.
  • 5Pollicinea T, Zanetti AR, Cacciola L, et al. Pre-S2 detective hepatitis B virus infections in patients with fulminant hepatitis [J]. Hepatology,1997, 26: 495-199.
  • 6Asahina Y, Enomoto N, Ogura Y, et al. Sequential changes in full-length genomes of hepatitis B virus accompanying acute exacerbation of chronic hepatitis B[J]. J Hepatol, 1996, 25(6):787-794.
  • 7Raimondo G, Costantino L, Caccamo G, et al. Non-sequencig molecular approaches to identify preS2-defective hepatitis B virus variants proved to be associated with severe liver diseases[J]. J Hepatol, 2004, 40(3): 515-519.
  • 8Hsieh YH, Su IJ, Wang HC, et al. Pre-S mutant surface antigens in chronic hepatitis B virus infection induce oxidative stress and DNA damage[J]. Carcinogenesis, 2004, 71 (1): 2023-2032.
  • 9Husa P, Chalupa P, Stroblova H, et al. Efficacy of alpha-interferon therapy of chronic hepatitis patients infected with wild type hepatitis B virus and HBeAg-minus mutant[J]. Acta Virologica, 2001, 45(5-6):293-297.
  • 10Erhardt A, Reineke U, Blondin D, et al. Mutations of the core promoter and response to interferon treatment in chronic replicative hepatitis B[J]. Hepatology, 2000, 31(3): 716-725.

二级参考文献33

  • 1Scaglioni PP,Melegari M,Wands JR.Biological properties of hepatitis B viral genomes with mutations in the precore promoter and precore open reading frame.Virology,1997,233(2) :374-381.
  • 2Jung MC,Diepoder HM,Spender U,et al.Activation of heterogeneous hepatitis B (HB) Core and a antigen-specific CD4 + T-cell population during serocoreversion to anti-HBe and anti-HBs in hepatitis B virus in fection.J Virol,1995,69(6) :3358-3368.
  • 3Andears E,Ulf R,Dirk B,et al.Mutations of the core promoter and response to interferon treatment in chronic replicative hepatitis B.Hepatology,2000,31: 716 -725.
  • 4Alien MI,Deslauriers M,Andrews CW,et al.Identification and characterisation of mutations in hepatitis B virus resistant to lamivudine.Hepatology,1998,27:1670-1677.
  • 5Liaw YF,Chien RN,Yeh CT,et al.Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapy [ comments ].Hepatology,1999,30 (2) :567-572.
  • 6Lai CL,Chien RN,Leung NW,et al.A one-year trial of lamivudine for chronic hepatitis B.N Engl J Med,1998,339(2) :61-68.
  • 7Liaw YF,Leung NW,Chang TI,et al.Effects of extended lamivudine THERAPY in Asian patients with chronic hepatitis B.Gastroenterology,2000,119(1):172-180.
  • 8Liaw YF,Chien RN,Yeh CT,et al.Acute exuoerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapy.Hepatology,1999,30:567-572.
  • 9Gunther S,Piwoom N,Will H.Wild type levels of pregenomic RNA and replication but reduced pre-C RNA and e-antigen synthesis of hepatitis B virus with C (1653)-T,A (1762)-T,and G (1764)-A mutations in the core promoter.J Gen Virol,1998,79:375-380.
  • 10Lindh M,Hannoun C,Dhillon AP,et al.Core promoter mutations and genotypes in relation to viral replication and liver injure in East Asian hepatitis B virus carriers.Infect Dis,1999,179(4) :775-782

共引文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部